Download: Preclinical Pharmacology of CNS and Related Diseases

Preclinical Pharmacology of CNS and Related Diseases
Preclinical Pharmacology of CNS and Related Diseases
Preclinical Pharmacology of CNS and Related Diseases

Integrated Electrophysiology & Behavioral Readouts for CNS Drug Development

 

Our CNS Platform offers a comprehensive suite of electrophysiological and behavioral tools — including EEG, LFP, evoked potentials, nerve conduction velocity, EMG, and fiber photometry — to characterize a wide range of CNS models. From theta–gamma phase–amplitude coupling (TG-PAC) as a translational biomarker for Alzheimer’s disease and neuropsychiatric drug evaluation, to LFP-based seizure quantification in the PTZ model, and objective sleep architecture analysis, our platform provides sensitive, mechanism-relevant readouts to support your CNS drug development.

Download the brochure to explore our full CNS capabilities and see how we can support your program.

 

 

 

 

 

 

 

 

Preclinical Pharmacology of CNS and Related Diseases

    -->